03782nam 22007454a 450 991045661360332120200520144314.066124545391-282-45453-697866124545301-60750-433-2(CKB)2550000000002860(EBL)476840(OCoLC)491261565(SSID)ssj0000422874(PQKBManifestationID)11277517(PQKBTitleCode)TC0000422874(PQKBWorkID)10432663(PQKB)10544252(MiAaPQ)EBC476840(Au-PeEL)EBL476840(CaPaEBR)ebr10363632(CaONFJC)MIL245453(EXLCZ)99255000000000286020090915d2009 uy 0engur|n|---|||||txtccrThe meaning of activities in the dwelling and residential environment[electronic resource] a structural approach in people-environment relations /door Janine MeestersAmsterdam IOS Press ;Delft Delft University Pressc20091 online resource (286 p.)Sustainable urban areas,1574-6410 ;27Originally presented as the author's thesis (doctoral)--Delft University of Technology, Delft, 2009.1-60750-012-4 Includes bibliographical references (p. 177-184).Title Page; Contents; Preface; Introducing the meaning of dwelling; Conceptualising the meaning of dwelling; Describing the context of dwelling; Analysing activities in the dwelling and the residential environment; The meaning of activities in the dwelling and residential environment; Comparing the meaning of dwelling; Conclusions and discussion; References; Appendix 1 Design and implementation of the questionnaire; Appendix 2 Key features of respondents; Appendix 3 Log linear analysis; Appendix 4 Preferred amenities; Appendix 5 Mentioned activities and the frequenciesAppendix 6 CA of everyday activitiesAppendix 7 Results logistic regression models: activities; Appendix 8 General meanings; Appendix 9 Results logistic regression models: general meanings of activities; Appendix 10 Universal value types; Appendix 11 Use of the dwelling; Appendix 12 Preferred location and main reason for preference; Appendix 13 Activities performed in the living room; Summary; Samenvatting (Dutch summary); Curriculum Vitae; Sustainable Urban AreasThe dwelling is a central setting in people's everyday life. People use their dwelling and residential environment for a large variety of activities and purposes. This book relates activities, settings and meanings to improve the insight into people-environment relations which is called a meaning structure approach.Sustainable urban areas ;27.HousingHousingResident satisfactionHousingPsychological aspectsHuman beingsEffect of environment onUrban ecology (Sociology)City and town lifeLifestylesElectronic books.Housing.HousingResident satisfaction.HousingPsychological aspects.Human beingsEffect of environment on.Urban ecology (Sociology)City and town life.Lifestyles.392.36Meesters Janine1981-860119MiAaPQMiAaPQMiAaPQBOOK9910456613603321The meaning of activities in the dwelling and residential environment1919127UNINA05131nam 2200589 450 991079754950332120200520144314.00-12-802550-6(CKB)3710000000468349(EBL)2197878(Au-PeEL)EBL2197878(CaPaEBR)ebr11306155(CaONFJC)MIL826972(OCoLC)919611878(NjHacI)993710000000468349(MiAaPQ)EBC2197878(PPN)19868634X(EXLCZ)99371000000046834920161202h20152015 uy 0engur|n|---|||||rdacontentrdamediardacarrierFood and drug regulation in an era of globalized markets /edited by Sam F. HalabiLondon, England :Academic Press,2015.©20151 online resource (258 p.)Includes index.0-12-802311-2 Front Cover; Food and Drug Regulation in an Era of Globalized Markets; Copyright; Contents; Contributors; Foreword; Introduction; The Rise of a Global System for Food and Pharmaceuticals; Conceptualizing Food and Drug Regulation in Globalized Markets: Interdisciplinarity and Governance; The Plan of This Book; Acknowledgments; Acknowledgments; Part I: Governance, Regulation, and Vulnerabilities of Globalized Pharmaceutical Supply Chains ; Chapter 1: Addressing Emerging Challenges in the Pharmaceutical Product Development Ecosystem; IntroductionApproaches to Reduce Drug Development Costs and Speed Innovation Clinical Trials: Reducing Costs, Speeding Development: New Approaches to Patient Recruitment, Study Design, and Settings; Adaptive Design; Clinical Trials: Globalization; New Approaches to Endpoints: Biomarkers, Patient Reporting, and Remote Monitoring; The Supply Chain: How Are We Vulnerable and What Are Potential Solutions?; Big (More and More) Data: Swim or Drown?; Conclusion; Chapter 2: FDA's Global Investigation and Enforcement Authority, Partnerships, and Priorities; Introduction; Adulteration, Misbranding, and GMPsFDA Establishment Inspections FDA Enforcement Instruments Related to Manufacturing; Foreign Inspections; Conclusion; Chapter 3: The European Medicines Agency and the Regulation of Medicines in the European Union; Introduction; Approval of Drugs in Europe; The European Medicines Agency: Its Role and Activities; Ema Support In The Early Stages Of Drug Development; The Centralized Procedure AT WORK; Assessment overview; Single Assessment Report; Patients in the Scientific Review Process; Transparency and the Centralized Procedure; EMA-FDA Cooperation; Cooperation in the Product Life CycleCooperation in Inspections Benefits of International Cooperation; References; Chapter 4: Human Clinical Trials and Drug Approvals: Transnational Issues; Introduction; Taking Clinical Trials Abroad; Overlapping Legal and Regulatory Requirements; Legal Landscape in the United States: FDA Oversight of Clinical Trials; Legal Landscape in the EU: EU Clinical Trial Directives and Regulation; International Legal Landscape: International Clinical Practice Standards; National and Local Legal Standards; Practical Considerations in Conducting Global TrialsDeciding Whether to Conduct the Foreign Clinical Trial Under an IND Identifying Experienced Contractors and Contract Research Organizations; Managing Idiosyncratic Foreign Sites and Investigators; Conclusion; Further Reading; Chapter 5: Falsified and Substandard Medicines in Globalized Pharmaceutical Supply Chains: Toward Actionable Solutions; Globalization's Influence on the Pharmaceutical Supply Chain; The Effects of the Global Market for Falsified and Substandard Medicines; Barriers to Global Solutions for the Problem of Falsified and Substandard MedicinesCombating Falsified and Substandard Medicines through Regulatory CooperationFood and Drug Regulation in an Era of Globalized Markets provides a synthesized look at the pressures that are impacting today's markets, including trade liberalization, harmonization initiatives between governments, increased aid activities to low-and middle-income countries, and developing pharmaceutical sectors in China and India. From the changing nature of packaged and processed food supply chains, to the reorientation of pharmaceutical research and funding coalesced to confront firms, regulators, and consumers are now faced with previously unknown challenges. Based on the 2014 O'DrugsLaw and legislationPharmacyLaw and legislationFood law and legislationDrugsLaw and legislation.PharmacyLaw and legislation.Food law and legislation.344.04233Halabi Sam F.MiAaPQMiAaPQMiAaPQBOOK9910797549503321Food and drug regulation in an era of globalized markets3794751UNINA01217nas 2200433 a 450 991017214090332120241221110103.0(CKB)954928517780(CONSER) 48042500(MiAaPQ)40992(DE-599)ZDB2067183-0(MiFhGG)3159(EXLCZ)9995492851778020760826a19479999 uy aengtxtrdacontentcrdamediacrrdacarrierWorld oil[Houston, Tex. Gulf Pub. Co.]1 online resourcePrint version: World oil (Houston, Tex.) (DLC) 48042500 0043-8790 PetroleumPeriodicalsPetroleumfast(OCoLC)fst01059260Industrie pétrolièrefreECLASMensuelsfreECLASPétrolefreECLASPeriodicals.fastPetroleumPetroleum.Industrie pétrolière.Mensuels.Pétrole.665.505JOURNAL9910172140903321exl_impl conversionWorld oil1949429UNINA